U.S. Suspends J&J Covid-19 Vaccine Shipments as States Face a Surplus of Expiring Doses--Update
June 10 2021 - 3:44PM
Dow Jones News
By Jared S. Hopkins and Betsy McKay
The U.S. government has halted new shipments of the Johnson
& Johnson Covid-19 vaccine, according to state and federal
health officials, one of several steps federal agencies are taking
that could help clear a backlog of unused doses before they
expire.
The U.S. Centers for Disease Control and Prevention has stopped
making available the one-dose shot to states, the state and federal
health officials said. The stoppage is believed to be temporary,
some of these officials said.
Health officials from Maryland, Oklahoma, Arkansas, Michigan,
Illinois and other states said they haven't been able to order new
supplies of J&J doses in recent weeks. Some also said they have
sufficient supply of the vaccine.
"It just hasn't been included in our weekly allocations, from
the feds, which means it is not available to order," said Oklahoma
State Department of Health Deputy Commissioner Keith Reed.
The move comes after The U.S. Food and Drug Administration
separately extended the shelf life of J&J's vaccine to 4 1/2
months from three months once refrigerated, the drugmaker said
Thursday.
A spokeswoman for the Arkansas state health department said it
was informed that no doses were available for ordering because of
issues related to the manufacturing of the vaccine.
It couldn't be determined why the federal government suspended
the shipments, but comes at a time when health officials are
pushing for the use of stockpiled J&J doses prior to their
expiration.
A J&J spokesman didn't respond to a request for comment on
the government's decision to limit availability of its vaccine to
states.
Just over half of the approximately 21 million of the J&J
doses distributed in the U.S. have been administered, a lower
percentage compared with shots from Pfizer Inc. and Moderna Inc.,
according to the CDC.
Hospital and state officials said they have many J&J doses
expiring later this month, partly as an unintended consequence of
the U.S.'s decision in April to temporarily suspend administration
of J&J doses to assess a rare blood-clot risk.
The pause forced states and providers to cancel large blocks of
appointments that were never rescheduled and left a surplus of
supply and, in some areas, increased hesitancy over the J&J
vaccine's safety.
The J&J vaccine was authorized by the U.S. Food and Drug
Administration in February after researchers found it to be
effective in a large-scale trial at protecting against symptomatic
Covid-19.
While its efficacy was slightly lower than Pfizer and Moderna
shots, public-health officials and vaccine experts had high hopes
for the shot's role in the vaccine drive -- because it was a
single-shot and required fewer cold-chain restrictions.
J&J stores doses frozen until shipment by the government, at
which point they are refrigerated. That is when the countdown
starts for expiration.
State health officials said they haven't been able to order new
doses of the J&J shot since mid-May. The CDC has been
restricting orders of the J&J vaccine, the federal health
official said.
Maryland last ordered J&J doses several weeks ago and has
since been told by the government that the vaccine isn't available,
Maryland Department of Health Assistant Secretary Bryan Mroz said
in an interview. Federal officials say J&J's shot will become
available again but didn't say when that would be, he said.
"We've been using up our inventory in the state," Mr. Mroz. "We
definitely have more supply than demand."
Mr. Mroz said that some doses will expire at the end of June and
others in July and that the state is working to redistribute some
to providers who request them.
States such as Wisconsin and Oklahoma have been asking the
federal government for guidance on what to do with expiring
doses.
For much of the rollout, states and providers had been
instructed by states and the federal government to dispose of
unused doses past their expiration date. Recently, some states say
they have been getting conflicting information.
Mr. Mroz said in an interview that the CDC on Tuesday
recommended the state put aside expiring J&J doses in storage
as the agency waited to learn from federal government reviews into
whether the shelf life can be extended. But he said the CDC then
changed that guidance on Wednesday and suggested expired doses
should still be discarded.
Thomas M. Burton and Julie Wernau contributed to this
article.
Write to Jared S. Hopkins at jared.hopkins@wsj.com and Betsy
McKay at betsy.mckay+1@wsj.com
(END) Dow Jones Newswires
June 10, 2021 15:39 ET (19:39 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.
Johnson and Johnson (NYSE:JNJ)
Historical Stock Chart
From Mar 2024 to Apr 2024
Johnson and Johnson (NYSE:JNJ)
Historical Stock Chart
From Apr 2023 to Apr 2024